Freedom Leaf (OTCQB:FRLF) has announced the introduction of Leafceuticals, a wholly owned division dedicated to providing distribution, standardized formulations and quality assurance for the natural whole-hemp full-spectrum ingredients in the Hempology brand product line and third party clients for private label.
As quoted in the press release:

Leafceuticals will also promote and manage sales of the NuAxon Tech line of CO2 Supercritical Extractors and our Las Vegas based extraction showroom facility.
Our lab-tested CBD oil in the Hempology line contains >60% pure full-spectrum CBD extract, which also includes cannabinoids like CBG, CBN, and CBC for comprehensive health benefits. To maximize effectiveness, additional therapeutic compounds like terpenes, phenols, and flavonoids are added to provide the full entourage effect. We utilize only the most beneficial supplements of 99% pure CBD isolate to our top-of-the-line nutraceutical formulations. Our natural CBD oil is produced from American-grown hemp crops and extracted in modern processing facilities.
CEO and President Clifford J Perry stated, “With and we are committed to enhancing human health and well-being by manufacturing and marketing superior nutraceutical ingredients that are positioned to excel in today’s demanding marketplace. We provide our customers with laboratory tested, non-gmo, full-spectrum CBD products for the rapidly expanding legal hemp industry. Our manufacturing facilities are FDA, GMP and PETA registered. We are committed to producing the finest in breathable vapors and topical blends from natural herbal and hemp extracts.”
Currently, we are in negotiations with multiple successful marketers that service the niche hemp industry: smoke shops, dispensaries, and natural health stores. We are also in serious discussions with a national distributor that works with convenience stores and big box chains, where we plan to open up new markets for hemp products.

Click here to read the full press release.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement, Harvest shareholders will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held.

Halper Sadeh encourages Harvest Health shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or or .

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, announced today the appointment of Cameron Wickham as a Director, Chief Executive Officer and Corporate Secretary of the Company and Ankit Gosain as Chief Financial Officer of the Company, effective May 7, 2021.

Daniel Pelchovitz, the Company’s former Chief Executive Officer, will continue with Spyder as a Director of the Company and as Chief Executive Officer of Spyder Cannabis Subco Inc., the Company’s Alcohol and Gaming Commission of Ontario (AGCO)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Niagara Falls, Ontario and has submitted two additional Retail Store Authorizations to the AGCO, and The Green Spyder Inc., the Company’s Alberta Gaming, Liquor & Cannabis (AGLC)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Calgary, Alberta.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.

1Q 2021 Financial Highlights (Unaudited)

Keep reading... Show less

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (OTC: HRVSF) in connection with the proposed acquisition of the Company by Trulieve Cannabis Corp. (“Trulieve”) (OTC: TCNNF). Under the terms of the merger agreement, Harvest shareholders will receive 0.1170 shares of Trulieve common stock for each Harvest share that they own, representing implied per-share merger consideration of approximately $4.79 based upon Trulieve’s May 7, 2021 closing price of $40.92 . Upon consummation of the transaction, current Harvest shareholders will own only 26.7% of the issued and outstanding pro forma Trulieve shares.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Participants may access a live webcast of the presentation by going to the Upcoming Events page at . A replay will be made available shortly following the live presentation.

Keep reading... Show less